Petra F.
- Country
- Czechia
- Department
- N/A
Research Overview
- Therapeutic Equivalence of CHF5993 Combination Therapy Using HFA-152a Versus HFA-134a in Adults With Mild to Moderate Asthma
- Randomized, Double‑Blind, Placebo‑Controlled Trial of Oral Dexpramipexole (KNS‑760704) as Add‑On to Standard Inhaled Therapy in Adolescents and Adults with Severe Eosinophilic Asthma
- Evaluation of the Efficacy and Safety of Fluticasone Propionate/Salbutamol Sulfate in Reducing Severe Asthma Exacerbations in Asthma Patients
Data & Insights
Has run more than one trial at 125 of 392 partner sites.
Specializations
Respiratory Disease Management
This investigator specializes in treating complex respiratory conditions, with particular emphasis on severe eosinophilic asthma and chronic obstructive pulmonary disease (COPD).
- Advanced Asthma Care
- COPD Treatment
- Chronic Bronchitis Management
The investigator focuses on patients with inadequately controlled respiratory conditions requiring specialized therapeutic approaches.
Therapeutic Innovation
Expertise in evaluating novel therapeutic combinations including inhaled corticosteroids, long-acting bronchodilators, and emerging respiratory medications.
- Combination Inhaler Therapies
- Novel Therapeutic Compounds
- Maintenance Treatment Strategies
The investigator explores innovative treatment approaches for patients with severe respiratory conditions.
Clinical Expertise
Specializes in treating patients with severe exacerbations and managing complex respiratory disease manifestations.
- Exacerbation Prevention
- Long-term Disease Control
- Treatment-resistant Cases
The investigator works with both adolescent and adult patient populations requiring advanced respiratory care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.